Yedgar S, Eilam O, Shafrir E
Am J Physiol. 1985 Jan;248(1 Pt 1):E10-4. doi: 10.1152/ajpendo.1985.248.1.E10.
The viscosity of the extracellular medium of cultured hepatocytes has been shown to be a regulator of the secretion and synthesis of very low-density lipoproteins (Yedgar et al., J. Biol. Chem. 257: 2188-2192, 1982). At present, the role of plasma viscosity in regulation of plasma lipoprotein levels was examined in vivo using nephrotic hyperlipidemic rats. Plasma viscosity was increased by injection of macromolecules: simultaneously with induction of nephrosis by aminonucleoside; and after the lipid level had reached its maximum. In experiment 1 the elevation of plasma viscosity (which persisted for at least 2 days) delayed the development of the hyperlipidemia by at least 2 days. In experiment 2 increasing the plasma viscosity reduced plasma triglyceride and cholesterol levels by 70 and 40%, respectively, within 2 days. The hyperlipidemia was accompanied by increased plasma viscosity. The contribution of lipoproteins to plasma viscosity was 27% in the nephrotic-hyperlipidemic rats, compared with 4% in normal rats. It is suggested that plasma viscosity regulates lipoprotein levels in vivo concordant with the observation in cultured hepatocytes.
培养的肝细胞细胞外介质的黏度已被证明是极低密度脂蛋白分泌和合成的调节因子(耶德加等人,《生物化学杂志》257: 2188 - 2192, 1982)。目前,利用肾病性高脂血症大鼠在体内研究了血浆黏度在调节血浆脂蛋白水平中的作用。通过注射大分子增加血浆黏度:在氨基核苷诱导肾病的同时;以及在血脂水平达到最大值之后。在实验1中,血浆黏度的升高(持续至少2天)使高脂血症的发展延迟了至少2天。在实验2中,增加血浆黏度在2天内分别使血浆甘油三酯和胆固醇水平降低了70%和40%。高脂血症伴随着血浆黏度的增加。在肾病性高脂血症大鼠中,脂蛋白对血浆黏度的贡献为27%,而正常大鼠中为4%。这表明血浆黏度在体内调节脂蛋白水平,与在培养肝细胞中的观察结果一致。